{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T08:09:49Z","timestamp":1772179789283,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.vaccine.2004.09.029","type":"journal-article","created":{"date-parts":[[2004,11,8]],"date-time":"2004-11-08T18:47:18Z","timestamp":1099939638000},"page":"1703-1708","source":"Crossref","is-referenced-by-count":80,"title":["Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants"],"prefix":"10.1016","volume":"23","author":[{"given":"Susanna","family":"Esposito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenza","family":"Pugni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Bosis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Proto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Cesati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciro","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Cimino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Principi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.09.029_bib1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/01.inf.0000066242.21072.9d","article-title":"Streptococcus pneumoniae-related illnesses in young children: secular trends and regional variation","volume":"22","author":"Poehling","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2004.09.029_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00006454-200202000-00011","article-title":"Six year multicenter surveillance of invasive pneumococcal infections in children","volume":"21","author":"Kaplan","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2004.09.029_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3201\/eid0805.010235","article-title":"Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children: implications for the use of heptavalent pneumococcal conjugate vaccine","volume":"8","author":"Marchiso","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2004.09.029_bib4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1086\/313609","article-title":"The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use. Part II","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.vaccine.2004.09.029_bib5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1542\/peds.113.3.443","article-title":"Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine","volume":"113","author":"Kaplan","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2004.09.029_bib6","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0264-410X(02)00807-1","article-title":"The potential indirect effect of conjugate pneumococcal vaccines","volume":"21","author":"O\u2019Brien","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.09.029_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1473-3099(01)00063-9","article-title":"Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance","volume":"1","author":"Klugman","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2004.09.029_bib8","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2004.09.029_bib9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2004.09.029_bib10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children: Northern California Kaiser Permanent Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2004.09.029_bib11","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1542\/peds.101.4.604","article-title":"Safety and immunogenicity of heptavalent pneumococcal vaccine conjugate to CRM 197 in United States infants","volume":"101","author":"Rennels","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2004.09.029_bib12","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics. Immunization of preterm and low birth weight infants. Pediatrics 2003;112:193\u20138.","DOI":"10.1542\/peds.112.1.193"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2004.09.029_bib13","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1007\/s00431-002-1064-z","article-title":"Safety and efficacy of the seven-valent pneumococcal conjugate vaccine: evidence from Northern California","volume":"161","author":"Black","year":"2002","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2004.09.029_bib14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00006454-200203000-00003","article-title":"Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants","volume":"21","author":"Shinefield","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2004.09.029_bib15","series-title":"Proceedings of the 21st Annual Meeting of the European Society for Paediatric Infectious Diseases","article-title":"Pneumococcal conjugate vaccine (PNCCRM) is immunogenic when administered at 3, 5 and 12 months of age","author":"Kayhty","year":"2003"},{"key":"10.1016\/j.vaccine.2004.09.029_bib16","unstructured":"American Academy of Pediatrics, Committee on Infectious Diseases. Immunization in special clinical circumstances. Preterm and low birth weight infants. In: American Academy of Pediatrics, editors. Red Book 2003: Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, IL; 2003. p. 66\u20138."},{"key":"10.1016\/j.vaccine.2004.09.029_bib17","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1016\/S0264-410X(02)00230-X","article-title":"Long-term pertussis-specific immune responses to a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine in pre-term infants","volume":"20","author":"Esposito","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.09.029_bib18","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1128\/IAI.69.7.4516-4520.2001","article-title":"Long-term pertussis-specific immunity after a primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine in comparison with natural infection","volume":"69","author":"Esposito","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.09.029_bib19","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0022-3476(97)80017-0","article-title":"Apnea after immunization of preterm infants","volume":"130","author":"Sanchez","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2004.09.029_bib20","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1016\/S0264-410X(03)00230-5","article-title":"Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants","volume":"21","author":"Jodar","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.09.029_bib21","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1016\/S0264-410X(03)00110-5","article-title":"Theoretic coverage of heptavalent pneumococcal conjugate vaccine in the prevention of community-acquired pneumonia in children in Italy","volume":"21","author":"Esposito","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.09.029_bib22","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/378740","article-title":"Serum concentrations of pneumococcal anti-capsular antibodies in children with pneumonia associated with Streptococcus pneumoniae infection","volume":"37","author":"Esposito","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2004.09.029_bib23","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1086\/344191","article-title":"Characteristics of Streptococcus pneumoniae and atypical bacteria infections in children 2 to 5 years of age with community-acquired pneumonia","volume":"35","author":"Esposito","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2004.09.029_bib24","first-page":"S84","article-title":"Standardization of antibody assays for measuring the response to pneumococcal infection and immunization","volume":"8","author":"Siber","year":"1989","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2004.09.029_bib25","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/CDLI.2.5.590-597.1995","article-title":"Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S","volume":"2","author":"Quataert","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2004.09.029_bib26","unstructured":"Centers for Disease Control and Prevention. Notice to readers: limited supply of pneumococcal conjugate vaccine: suspension of recommendation for fourth dose. MMWR 2004;53:108\u20139."},{"key":"10.1016\/j.vaccine.2004.09.029_bib27","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jama.289.5.575","article-title":"Variation in public and private supply of pneumococcal conjugate vaccine during a shortage","volume":"289","author":"Freed","year":"2003","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2004.09.029_bib28","unstructured":"Centers for Disease Control and Prevention. Limited supply of pneumococcal conjugate vaccine. MMWR 2003;52:1234."},{"key":"10.1016\/j.vaccine.2004.09.029_bib29","unstructured":"Centers for Disease Control and Prevention. Update recommendations on the use of pneumococcal conjugate vaccine in a setting of vaccine shortage. Advisory Committee on Immunization Practices. J Am Med Soc 2002;287:833\u20134."},{"key":"10.1016\/j.vaccine.2004.09.029_bib30","unstructured":"Centers for Disease Control and Prevention. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2000;49(RR9)."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04007340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04007340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T22:33:30Z","timestamp":1585953210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04007340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":30,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0264410X04007340"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.09.029","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}